Pharmaceutical - Financial, Teva Pharmaceutical Industries

Filter

Popular Filters

Teva provides 2014 financial outlook expecting big hit from Copaxone generics

Teva provides 2014 financial outlook expecting big hit from Copaxone generics

11-12-2013

Israel’s Teva Pharmaceutical Industries is itself bracing for competition from copies to its best-selling…

CopaxoneFinancialNeurologicalPharmaceuticalTeva Pharmaceutical Industries

Teva denies claims its MS drug Copaxone profits set to slump

Teva denies claims its MS drug Copaxone profits set to slump

25-11-2013

Israel’s Teva Pharmaceutical Industries, the world’s largest generic drugmaker, this morning strongly…

CopaxoneEuropeFinancialMylan LaboratoriesNeurologicalPatentsPharmaceuticalTeva Pharmaceutical Industries

Analysts recommend GSK after Teva announces Advair generic delay

Analysts recommend GSK after Teva announces Advair generic delay

11-10-2013

The delay for the generic version of GlaxoSmithKline’s Advair coupled with the advances in the company’s…

AdvairdarapladibEuropeFinancialGlaxoSmithKlineNeurologicalPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

Yaroslavl region of Russia to become major center for the country’s pharmaceutical production

05-10-2013

The Russian Yaroslavl region is expected to become one of the major centers of the country’s pharmaceutical…

AbbVieCadila PharmaceuticalsEuropeFinancialPharmaceuticalProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

Teva Pharma sees slowdown in generic revenues

01-08-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world largest generics firm but with a…

CopaxoneFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Alexza deal with Teva sets stage for Adasuve, say analysts

23-05-2013

USA-based Alexza Pharmaceuticals' (Nasdaq: ALXA) US marketing deal with Israel-headquartered Teva Pharmaceutical…

AdasuveAlexza PharmaceuticalAZ-002FinancialLicensingNeurologicalPharmaceuticalTeva Pharmaceutical Industries

Teva 1st-qtr sales and profits decline

02-05-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) says that first-quarter 2013 net revenue dipped…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Merck & Co to pay $688 million to settle investor law suits; Teva could face $2.1 billion damages

15-02-2013

US pharma giant Merck & Co (NYSE: MRK) said yesterday that it has reached an agreement in principle with…

FinancialGenericsLegalMerck & CoPharmaceuticalProtonixTeva Pharmaceutical IndustriesVytorinZetia

Teva Pharma's 4th-qtr financials just misses forecasts

08-02-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) reported results for the fourth quarter 2012,…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva fleshes out restructuring plan; licenses Xenon pain drug for $376 million

12-12-2012

Teva Pharmaceutical Industries (NYSE: TEVA's new chief executive Jeremy Levin has outlined the company's…

CopaxoneFinancialGenericsLicensingPatentsPharmaceuticalResearchTeva Pharmaceutical IndustriesXenon Pharmaceuticals

Teva Pharma's earnings beat forecasts, but sales lower than expected

02-11-2012

Israel-headquartered Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs maker…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

M&A briefs: GlaxoSmithKline/Response Genetics; Bayer/Teva unit

16-09-2012

USA-based Response Genetics (Nasdaq: RGDX) last week entered into a purchase agreement with UK pharma…

BayerBiotechnologyFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResponse GeneticsTeva Pharmaceutical Industries

Johnson & Johnson close to settling over Risperdal marketing; SEC probes Teva

06-08-2012

US health care giant Johnson & Johnson (NYSE: JNJ) has reached "an agreement in principle'' with the…

FinancialGenericsInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalTeva Pharmaceutical Industries

Teva's EPS rockets, helped by higher sales in USA

03-08-2012

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs producer…

CephalonFinancialGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

Novartis and Teva announce expansion plans in Russia

05-07-2012

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia's largest…

EuropeFinancialGenericsMarkets & MarketingNovartisPharmaceuticalRT-BiotechpromTeva Pharmaceutical Industries

Teva lowers full-year 2012 forecasts

25-05-2012

Israel-based generic drug major Teva Pharmaceutical Industries (Nasdaq: TEVA) has provided its current…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Israel'sTeva beats expectations with 40% leap in profit

09-05-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) has reported a robust set of first-quarter…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva and OncoGenex update on prostate cancer drug development; loss widens at latter

12-03-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) and US/Canadian partner OncoGenex Pharmaceuticals…

BiotechnologycustirsenFinancialLicensingOncoGenexPharmaceuticalResearchTeva Pharmaceutical Industries

Teva Pharma strong sales growth helped by acquisitions

16-02-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) reported fourth-quarter 2011 results…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva to make massive share buy-back; expects $22 billion sales for 2011

22-12-2011

Israel-based generic drugs giant Teva Pharmaceutical Industries (Nasdaq: TEVA) has announced it plans…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Generics giant Teva posts 3rd-qtr 2011 sales rise but net income down 13%

02-11-2011

The world’s largest generic drugs maker, Teva Pharmaceutical Industries (Nasdaq: TEVA), has reported…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Sanofi to top Pfizer as number one for global pharma sales

01-11-2011

French drug major Sanofi (Euronext: SAN) is expected to take the top spot amongst the world’s pharmaceuticals…

FinancialGlobalJohnson & JohnsonMarkets & MarketingMerck & CoMergers & AcquisitionsNovartisNovo NordiskPfizerPharmaceuticalSanofiTakeda PharmaceuticalsTeva Pharmaceutical Industries

Company Spotlight

ImmunoGen

ImmunoGen

Back to top